Abstract
A 46 years old HIV reactive patient developed Stevens Johnson syndrome (SJS) probably due to nevirapine and/or co-trimoxazole. Patient was on zidovudine + lamivudine + nevirapine along with Co-trimoxazole since last two months. After 15 days, zidovudine was replaced with stavudine due to development of anemia. All these drugs were stopped after development of reaction. Temporal association was found between stavudine, lamivudine, nevirapine, cotrimoxazole and development of the reaction. Nevirapine and Co-trimoxazole were suspected to cause this reaction most probably due to associated hepatotoxicity and their common potential to cause SJS. In our case, patient died despite stopping of all medications.
Keywords: Anti-retroviral therapy, Co-trimoxazole, Hepatotoxicity, HIV, Nevirapine, Stevens Johnson syndrome, Adverse drug reaction.
Current Drug Safety
Title:Nevirapine and/or Co-Trimoxazole Induced Stevens Johnson syndrome in HIV Infected Patient - A Case Report
Volume: 8 Issue: 1
Author(s): Kaksha Patel, Ashwin Panchasara, Bhargav Purohit and C.B. Tripathi
Affiliation:
Keywords: Anti-retroviral therapy, Co-trimoxazole, Hepatotoxicity, HIV, Nevirapine, Stevens Johnson syndrome, Adverse drug reaction.
Abstract: A 46 years old HIV reactive patient developed Stevens Johnson syndrome (SJS) probably due to nevirapine and/or co-trimoxazole. Patient was on zidovudine + lamivudine + nevirapine along with Co-trimoxazole since last two months. After 15 days, zidovudine was replaced with stavudine due to development of anemia. All these drugs were stopped after development of reaction. Temporal association was found between stavudine, lamivudine, nevirapine, cotrimoxazole and development of the reaction. Nevirapine and Co-trimoxazole were suspected to cause this reaction most probably due to associated hepatotoxicity and their common potential to cause SJS. In our case, patient died despite stopping of all medications.
Export Options
About this article
Cite this article as:
Patel Kaksha, Panchasara Ashwin, Purohit Bhargav and Tripathi C.B., Nevirapine and/or Co-Trimoxazole Induced Stevens Johnson syndrome in HIV Infected Patient - A Case Report, Current Drug Safety 2013; 8 (1) . https://dx.doi.org/10.2174/1574886311308010011
DOI https://dx.doi.org/10.2174/1574886311308010011 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the <i>“Cytokine Release (Storm) Syndrome”</i> Caused by SARS-CoV-2?
Current Pharmaceutical Design Editorial [Hot topic: Stroke as a Target in Medicinal Chemistry and Drug Discovery (Guest Editor: Antonino Tuttolomondo)]
Current Topics in Medicinal Chemistry Antiviral Therapy Targeting Viral Polymerase
Current Pharmaceutical Design Neurokinin-1 Receptor (NK-1R) Antagonists: Potential Targets in the Treatment of Glioblastoma Multiforme
Current Medicinal Chemistry QSAR and Molecular Docking Directed Synthesis and Preliminary Evaluation of Novel Non-Nucleoside HCV NS5B Polymerase Inhibitors
Anti-Infective Agents Of Minibody, Camel and Bacteriophage
Combinatorial Chemistry & High Throughput Screening Molecular Targets and Angiogenesis in Renal Cell Carcinoma, A Multitarget Approach: Mini Review
Current Drug Targets The Pattern of Abbreviation Use in Prescriptions: A Way Forward in Eliminating Error-Prone Abbreviations and Standardisation of Prescriptions
Current Drug Safety Current and Emerging Therapeutic Approaches in HCV-Related Mixed Cryoglobulinemia
Current Medicinal Chemistry Patent Selections
Recent Patents on Materials Science Physiological and Pathophysiological Roles of ATP-Sensitive K+ Channels in Vascular Smooth Muscle
Vascular Disease Prevention (Discontinued) Cell-free DNA: Characteristics, Detection and its Applications in Myocardial Infarction
Current Pharmaceutical Design Update on Pharmacologic Retinal Vascular Toxicity
Current Pharmaceutical Design Will Diverse Tat Interactions Lead to Novel Antiretroviral Drug Targets?
Current Drug Targets Patent Selections:
Recent Patents on Anti-Infective Drug Discovery Conformational Diseases and Structure-Toxicity Relationships: Lessons from Prion-Derived Peptides
Current Protein & Peptide Science Biological Significance of Polymorphism in Legume Protease Inhibitors from the Bowman-Birk Family
Current Protein & Peptide Science Breaking the Barrier in Stroke: What Should we Know? A Mini-Review
Current Pharmaceutical Design Differential Action of Phytochemicals on Platelet Apoptosis: A Biological Overview
Current Medicinal Chemistry The Dynamic TRPA1 Channel: A Suitable Pharmacological Pain Target?
Current Pharmaceutical Biotechnology